Abstract：Objective To detect plasma N-terminal-pro-B-type-natriuretic-peptide changes in diabetic dialysis patients and assess the diagnostic value of NT-proBNP for left ventricular dysfunction.Methods Plasma BNP concentration was measured in 46 dialysis patients.Left ventricular end diastolic diameter(LVDd) and left ventricular ejection fraction(LVEF)were determined. The relationship between the levels of plasma NT-proBNP and cardiac function was compared.Results (1)The level of plasma NT-proBNP in diabetic dialysis patients was higher than the levels of plasma NT-proBNP in hemodialysis patients without diabetes. (2) More diabetic dialysis patients are complicated by left ventricular dysfunction than patients without diabetes. The levels of plasma NT-proBNP in diabetic dialysis patients with complicated left ventricular dysfunction were significant higher than patients with normal cardiac function. Conclusions The increase in NT-proBNP concentration can reflect the combination of chronic left ventricular dysfunction in diabetic dialysis patients in a certain extent.
刘建春,于 华,吕 豪. 脑钠肽前体对于糖尿病透析患者心功能评价的临床意义[J]. 武警医学, 2013, 24(5): 417-419.
LIU Jianchun,YU Hua,and LV Hao. Value of N-terminal-pro-B-type-natriuretic-peptide for left ventricular dysfunction in diabetic dialysis patients. Med. J. Chin. Peop. Armed Poli. Forc., 2013, 24(5): 417-419.
Paulus W J, Tschöpe C, Sanderson J E, et al.How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the Euro-pean Society of Cardiology[J]. Eur Heart J,2007,28(6):2539-2550.
[1]
Paulus W J, Tschöpe C, Sanderson J E, et al.How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the Euro-pean Society of Cardiology[J]. Eur Heart J,2007,28(6):2539-2550.
[2]
Tschöpe C, Kasner M, Westermann D, et al. The role of NT-pro BNP in the diagnostics of isolated diastolic dysfunction: correlation with echocardiographic and invasive mea-surements[J]. Eur Heart J,2005,26(5):2277-2284.
[2]
Tschöpe C, Kasner M, Westermann D, et al. The role of NT-pro BNP in the diagnostics of isolated diastolic dysfunction: correlation with echocardiographic and invasive mea-surements[J]. Eur Heart J,2005,26(5):2277-2284.
[3]
Rostoker G, Griuncelli M, Loridon C, et al. Left-ventricular diastolic dysfunction as a risk factor for dialytic hypotension[J]. Cardiology, 2009,114:142-149.
[3]
Rostoker G, Griuncelli M, Loridon C, et al. Left-ventricular diastolic dysfunction as a risk factor for dialytic hypotension[J]. Cardiology, 2009,114:142-149.
Wang A Y, Lam C W, Wang M, et al. Diagnostic potential of serum biomarkers for left ventricular abnormalities in chronic peritoneal dialysis patients[J]. Nephrol Dial Transplant,2009,24(6):1962-1969.
[5]
Wang A Y, Lam C W, Wang M, et al. Diagnostic potential of serum biomarkers for left ventricular abnormalities in chronic peritoneal dialysis patients[J]. Nephrol Dial Transplant,2009,24(6):1962-1969.
[6]
Manes M T, Gagliardi M, Misuraca G, et al.Left ventricular geometric patterns and cardiac function in patients with chronic renal failure undergoing hemodialysis[J].Monaldi Arch Chest Dis,2005,64(1):27-32.
[6]
Manes M T, Gagliardi M, Misuraca G, et al.Left ventricular geometric patterns and cardiac function in patients with chronic renal failure undergoing hemodialysis[J].Monaldi Arch Chest Dis,2005,64(1):27-32.
[7]
Park S, Cho G Y, Kim S G,et al. Brain natriuretic peptide levels have diagnostic and prognostic capability for cardio-renal syndrome type 4 in intensive care unit patients[J]. Crit Care,2009,13(3):7867-7878.
[7]
Park S, Cho G Y, Kim S G,et al. Brain natriuretic peptide levels have diagnostic and prognostic capability for cardio-renal syndrome type 4 in intensive care unit patients[J]. Crit Care,2009,13(3):7867-7878.
[8]
Winkler K, Wanner C, Drechsler C, et al. Change in N-terminal-pro-B-type-natriuretic-peptide and the risk of sudden death, stroke, myocardial infarction, and all-cause mortality in diabetic dialysis patients[J]. Eur Heart J,2008,29(17):2092-2099.
[8]
Winkler K, Wanner C, Drechsler C, et al. Change in N-terminal-pro-B-type-natriuretic-peptide and the risk of sudden death, stroke, myocardial infarction, and all-cause mortality in diabetic dialysis patients[J]. Eur Heart J,2008,29(17):2092-2099.
[9]
Satyan S, Light R P, Agarwal R. Relationships of N-terminal pro-B-natriuretic peptide and cardiac troponin T to left ventricular mass and function and mortality in asymptomatic hemodialysis patients[J]. Am J Kidney Dis,2007,50(6):1009-1019.
[9]
Satyan S, Light R P, Agarwal R. Relationships of N-terminal pro-B-natriuretic peptide and cardiac troponin T to left ventricular mass and function and mortality in asymptomatic hemodialysis patients[J]. Am J Kidney Dis,2007,50(6):1009-1019.
[10]
Lee J A, Kim D H, Yoo S J,et al. Association between serum n-terminal pro-brain natriuretic peptide concentration and left ventricular dysfunction and extracellular water in continuous ambulatory peritoneal dialysis patients[J]. Perit Dial Int,2006,26(3):360-365.
[10]
Lee J A, Kim D H, Yoo S J,et al. Association between serum n-terminal pro-brain natriuretic peptide concentration and left ventricular dysfunction and extracellular water in continuous ambulatory peritoneal dialysis patients[J]. Perit Dial Int,2006,26(3):360-365.
[11]
Januzzi J L,Kimmenade R,Lainchbury J,et al.NT proBNP testing for diagnosis and short term prognosis in acute destabilized heart failure:an international pooled analysis of 1256 patients[J].Eur Heart J,2006,27(3):330-337.
[11]
Januzzi J L,Kimmenade R,Lainchbury J,et al.NT proBNP testing for diagnosis and short term prognosis in acute destabilized heart failure:an international pooled analysis of 1256 patients[J].Eur Heart J,2006,27(3):330-337.
[12]
Saudan P, Kossovsky M, Halabi G, et al. Quality of care and survival of haemodialysed patients in western Switzerland[J].NephrolDial Transplant, 2008,23(2):1975-1981.
[12]
Saudan P, Kossovsky M, Halabi G, et al. Quality of care and survival of haemodialysed patients in western Switzerland[J].NephrolDial Transplant, 2008,23(2):1975-1981.
[13]
Bargnoux A S, Klouche K, Fareh J,et al. Prohormone brain natriuretic peptide (proBNP), BNP and N-terminal-proBNP circulating levels in chronic hemodialysis patients[J]. Clin Chem Lab Med,2008,46(7):1019-1024.
[13]
Bargnoux A S, Klouche K, Fareh J,et al. Prohormone brain natriuretic peptide (proBNP), BNP and N-terminal-proBNP circulating levels in chronic hemodialysis patients[J]. Clin Chem Lab Med,2008,46(7):1019-1024.
[14]
Breidthardt T, Moser-Bucher C, Praehauser C, et al. Morbidity and mortality on chronic hemodialysis: a ten-year Swiss single centre analysis[J]. Swiss Med Wkly, 2011, 141(8):13150-13154.
[14]
Breidthardt T, Moser-Bucher C, Praehauser C, et al. Morbidity and mortality on chronic hemodialysis: a ten-year Swiss single centre analysis[J]. Swiss Med Wkly, 2011, 141(8):13150-13154.
2013, Vol. 24 
